Association of CYP2E1, GST and mEH genetic polymorphisms with urinary acrylamide metabolites in workers exposed to acrylamide

Toxicology Letters

Volumn 203, Issue 2, 2011, Pages 118-126

  Huang, Yu Fang ^a,b   Chen, Mei Lien ^a   Liou, Saou Hsing ^b   Chen, Ming Feng ^b   Uang, Shi Nian ^c   Wu, Kuen Yuh ^d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c INSTITUTE OF OCCUPATIONAL SAFETY AND HEALTH   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Acrylamide; Cytochrome P450 2E1; Genetic polymorphisms; Glutathione transferases; Microsomal epoxide hydrolase

Indexed keywords

ACRYLAMIDE; ACRYLAMIDE DERIVATIVE; CYTOCHROME P450 2E1; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; GLYCIDAMIDE; N ACETYL(1 CARBAMOYL 2 HYDROXYETHYL)CYSTEINE; N ACETYL(2 CARBAMOYL 2 HYDROXYETHYL)CYSTEINE; N ACETYL(2 CARBAMOYLETHYL)CYSTEINE; UNCLASSIFIED DRUG;

AIR SAMPLING; ARTICLE; CHEMICAL INTERACTION; DETOXIFICATION; ELECTROSPRAY MASS SPECTROMETRY; ENZYME METABOLISM; FEMALE; GENETIC POLYMORPHISM; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; URINALYSIS; URINARY EXCRETION;

ACRYLAMIDE; ADULT; CYTOCHROME P-450 CYP2E1; DNA; EPOXIDE HYDROLASES; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MULTIVARIATE ANALYSIS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS;

EID: 79955479432     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.03.008     Document Type: Article

References (55)

1. Arand M., Mühlbauer R., Hengstler J., Jäger E., Fuchs J., Winkler L., Oesch F. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione-S-transferase GSTM1 and GSTT1 polymorphisms. Anal. Biochem. 1996, 236(1):184-186.
2. Besaratinia A., Pfeifer G.P. DNA adduction and mutagenic properties of acrylamide. Mutat. Res. 2005, 80:31-40.
3. Bjellaas T., Janak K., Lundanes E., Kronberg L., Becher G. Determination and quantification of urinary metabolites after dietary exposure to acrylamide. Xenobiotica 2005, 35(10-11):1003-1018.
4. Bjellaas T., Stølen L.H., Haugen M., Paulsen J.E., Alexander J., Lundanes E., Becher G. Urinary acrylamide metabolites as biomarkers for short-term dietary exposure to acrylamide. Food Chem. Toxicol. 2007, 45(6):1020-1026.
5. Bjellaas T., Olesen P.T., Frandsen H., Haugen M., Stølen L.H., Paulsen J.E., Alexander J., Lundanes E., Becher G. Comparison of estimated dietary intake of acrylamide with hemoglobin adducts of acrylamide and glycidamide. Toxicol. Sci. 2007, 98(1):110-117.
6. Boettcher M.I., Angerer J. Determination of the major mercapturic acids of acrylamide and glycidamide in human urine by LC-ESI-MS/MS. J. Chromatogr. B 2005, 824:283-294.
7. Boettcher M.I., Schettgen T., Kutting B., Pischetsrieder M., Angerer J. Mercapturic acids of acrylamide and glycidamide as biomarkers of the internal exposure to acrylamide in the general population. Mutat. Res. 2005, 580(1-2):167-176.
8. Bull R.J., Robinson M., Laurie R.D., Stoner G.D., Greisiger E., Meier J.R., Stober J. Carcinogenic effects of acrylamide in sencar and A/J mice. Cancer Res. 1984, 44:107-111.
9. Calleman C.J., Wu Y., He F., Tian G., Bergmark E., Zhang S., Deng H., Wang Y., Crofton K.M., Fennell T., Costa L.G. Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol. Appl. Pharmacol. 1994, 126(2):361-371.
10. Chevolleau S., Jacques C., Canlet C., Tulliez J., Debrauwer L. Analysis of hemoglobin adducts of acrylamide and glycidamide by liquid chromatography-electrospray ionization tandem mass spectrometry, as exposure biomarkers in French population. J. Chromatogr. A 2007, 1167(2):125-134.
11. Doerge D.R., Young J.F., McDaniel P., Twaddle N.C., Churchwell M.I. Toxicokinetics of acrylamide and glycidamide in Fischer 344 rats. Toxicol. Appl. Pharmacol. 2005, 208:199-209.
12. Doroshyenko O., Fuhr U., Kunz D., Frank D., Kinzig M., Jetter A., Reith Y., Lazar A., Taubert D., Kirchheiner J., Baum M., Eisenbrand G., Berger F.I., Bertow D., Berkessel A., Sörgel F., Schömig E., Tomalik-Scharte D. In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans. Cancer Epidemiol. Biomarkers Prev. 2009, 18(2):433-443.
13. Duale N., Bjellaas T., Alexander J., Becher G., Haugen M., Paulsen J.E., Frandsen H., Olesen P.T., Brunborg G. Biomarkers of human exposure to acrylamide and relation to polymorphisms in metabolizing genes. Toxicol. Sci. 2009, 108(1):90-99.
14. EPA Preliminary Assessment of Health Risks from Exposure to Acrylamide 1988, Office of Toxic Substances, US EPA, Washington.
15. Fennell T.R., Sumner S.C.J., Snyder R.W., Burgess J., Spicer R., Bridson W.E., Friedman M.A. Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol. Sci. 2005, 85(1):447-459.
16. Fennell T.R., Sumner S.C.J., Snyder R.W., Burgess J., Friedman M.A. Kinetics of elimination of urinary metabolites of acrylamide in humans. Toxicol. Sci. 2006, 93(2):256-267.
17. Friedman M.A., Dulak L.H., Stedham M.A. A lifetime oncogenicity study in rats with acrylamide. Fundam. Appl. Toxicol. 1995, 27:95-105.
18. Ghanayem B.I., McDaniel L.P., Churchwell M.I., Twaddle N.C., Snyder R., Fennell T.R., Doerge D.R. Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts. Toxicol. Sci. 2005, 88(2):311-318.
19. Hagmar L., Tornqvist M., Nordander C., Rosen I., Bruze M., Kautiainen A., Magnusson A.L., Malmberg B., Aprea P., Granath F., Axmon A. Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose. Scand. J. Work Environ. Health 2001, 27:219-226.
20. Hartmann E.C., Boettcher M.I., Schettgen T., Fromme H., Drexler H., Angerer J. Hemoglobin adducts and mercapturic acid excretion of acrylamide and glycidamide in one study population. J. Agric. Food Chem. 2008, 56(15):6061-6068.
21. Hartmann E.C., Boettcher M.I., Bolt H.M., Drexler H., Angerer J. N-acetyl-S-(1-carbamoyl-2-hydroxy-ethyl)-l-cysteine (iso-GAMA) a further product of human metabolism of acrylamide: comparison with the simultaneously excreted other mercapturic acids. Arch. Toxicol. 2009, 83:731-734.
22. Hassett C., Alcher L., Sidhu J.S., Omieclnskl C.J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet. 1994, 3(3):421-428.
23. Hildesheim A., Chen C.J., Caporaso N.E., Cheng Y.J., Hoover R.N., Hsu M.M., Levine P.H., Chen I.H., Chen J.Y., Yang C.S. Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan. Cancer Epidemiol. Biomarkers Prev. 1995, 4(6):607-610.
24. Huang C.C.J., Li C.M., Wu C.F., Jao S.P., Wu K.Y. Analysis of urinary N-acetyl-S-(propionamide)-cysteine as a biomarker for the assessment of acrylamide exposure in smokers. Environ. Res. 2007, 104(3):346-351.
25. Huang Y.F., Wu K.Y., Liou S.H., Uang S.N., Chen C.C., Shih W.C., Lee S.C., Huang C.C., Chen M.L. Biological monitoring for occupational acrylamide exposure from acrylamide production workers. Int. Arch. Occup. Environ. Health 2010, 10.1007/s00420-010-0558-7.
26. IARC, 1994. Acrylamide. In: IARC Monographs on the Evaluation of Carcinogen Risk to Humans: Some Industrial Chemicals. International Agency for Research on Cancer, pp. 389-433.
27. Jaffe M. Uber den niederschlag, welchen pikriksaure in normalen harn erzeugt und uber eine neue reaction des kreatinins. Z. Physiol. Chem. 1886, 10:391.
28. Johnson K.A., Gorzinski S.J., Bodner K.M., Campbell R.A., Wolf C.H., Friedman M.A., Mast R.W. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol. Appl. Pharmacol. 1986, 85:154-168.
29. Kellert M., Scholz K., Wagner S., Dekant W., Volkel W. Quantitation of mercapturic acids from acrylamide and glycidamide in human urine using a column switching tool with two trap columns and electrospray tandem mass spectrometry. J. Chromatogr. A 2006, 1131(1-2):58-66.
30. Kirman C.R., Gargas M.L., Deskin R., Tonner-Navarro L., Andersen M.E. A physiologically based pharmacokinetic model for acrylamide and its metabolites, glycidamide, in the rat. J. Toxicol. Environ. Health A 2003, 66(3):253-274.
31. Kopp E.K., Sieber M., Kellert M., Dekant W. Rapid and sensitive HILIC-ESI-MS/MS quantitation of polar metabolites of acrylamide in human urine using column switching with an online trap column. J. Agric. Food Chem. 2008, 56(21):9828-9834.
32. Kopp E.K., Dekant W. Toxicokinetics of acrylamide in rats and humans following single oral administration of low doses. Toxicol. Appl. Pharmacol. 2009, 235:135-142.
33. Kjuus H., Goffeng L.O., Heier M.S., Sjoholm H., Ovrebo S., Skaug V., Paulsson B., Tornqvist M., Brudal S. Effects on the peripheral nervous system of tunnel workers exposed to acrylamide and N-methylolacrylamide. Scand. J. Work Environ. Health 2004, 30:21-29.
34. Lei Y.C., Hwang S.J., Chang C.C., Kuo H.W., Luo J.C., Chang M.J., Cheng T.J. Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutat. Res. 2002, 519(1-2):93-101.
35. Li C.M., Hu C.W., Wu K.Y. Quantification of urinary N-acetyl-S-(propionamide)cysteine using an on-line clean-up system coupled with liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 2005, 40(4):511-515.
36. Lin P., Wang S.L., Wang H.J., Chen K.W., Lee H.S., Tsai K.J., Chen C.Y., Lee H. Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma. Br. J. Cancer 2000, 82(4):852-857.
37. NSC, 2006. Chemical Backgrounders Index: Acrylamide. Available at Accessed on 22 June 2009. http://www.environmentwriter.org/resources/backissues/chemicals/acrylamide.htm.
38. Paulsson B., Rannug A., Henderson A.P., Golding B.T., Törnqvist M., Warholm M. In vitro studies of the influence of glutathione transferases and epoxide hydrolase on the detoxification of acrylamide and glycidamide in blood. Mutat. Res. 2005, 580(1-2):53-59.
39. Sarmanova J., Tynkova L., Susova S., Gut I., Soucek P. Genetic polymorphisms of biotransformation enzymes: allele frequencies in the population of the Czech Republic. Pharmacogenetics 2000, 10(9):781-788.
40. Settels E., Bernauer U., Palavinskas R., Klaffke H.S., Gundert-Remy U., Appel K.E. Human CYP2E1 mediates the formation of glycidamide from acrylamide. Arch. Toxicol. 2008, 82(10):717-727.
41. Smith C.J., Perfetti T.A., Rumple M.A., Rodgman A., Doolittle D.J. " IARC Group 2A Carcinogens" reported in cigarette mainstream smoke. Food Chem. Toxicol. 2000, 38:371-383.
42. Smith E.A., Oehme F.W. Acrylamide and polyacrylamide: a review of production, use, environmental fate and neurotoxicity. Rev. Environ. Health 1991, 9(4):215-228.
43. Smith C.A., Harrison D.J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997, 350(9078):630-633.
44. Stephens E.A., Taylor J.A., Kaplan N., Yang C.H., Hsieh L.L., Lucier G.W., Bell D.A. Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics 1994, 4:185-192.
45. Strange R.C., Jones P.W., Fryer A.A. Glutathione S-transferase: genetics and role in toxicology. Toxicol. Lett. 2000, 112-113:357-363.
46. 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 1992, 5(1):81-89.
47. Sumner S.C., Selvaraj L., Nauhaus S.K., Fennell T.R. Urinary metabolites from F344 rats and B6C3F1 mice coadministered acrylamide and acrylonitrile for 1 or 5 days. Chem. Res. Toxicol. 1997, 10(10):1152-1160.
48. Sumner S.C., Fennell T.R., Moore T.A., Chanas B., Gonzalez F., Ghanayem B.I. Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem. Res. Toxicol. 1999, 12:1110-1116.
49. Tareke E., Rydberg P., Karlsson P., Eriksson S., Tornqvist M. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J. Agric. Food. Chem. 2002, 50(17):4998-5006.
50. Tareke E., Twaddle N.C., McDaniel P., Churchwell M.I., Young J.F., Doerge D.R. Relationships between biomarkers of exposure and toxicokinetics in Fischer 344 rats and B6C3F1 mice administered single doses of acrylamide and glycidamide and multiple doses of acrylamide. Toxicol. Appl. Pharmacol. 2006, 217:63-75.
51. Urban M., Kavvadias D., Riedel K., Scherer G., Tricker A.R. Urinary mercapturic acids and a hemoglobin adduct for the dosimetry of acrylamide exposure in smokers and nonsmokers. Inhal. Toxicol. 2006, 18(10):831-839.
52. US EPA Acrylamide (CASRN 79-06-1), Integrated Risk Information System 2010, Available at http://www.epa.gov/iris/subst/0286.htm. Accessed on 19 January 2011.
53. Wu K.Y., Huang Y.F., Chen M.F., Shih T.S., Uang S.N., Mao I.F., Chen M.L. Exposure assessment of airborne acrylamide for occupationally-exposed workers by using an isotope-dilution gas chromatography coupled with mass spectrometry. Ann. Occup. Hyg. 2010, 10.1093/annhyg/meq010.
54. Wu M.S., Chen C.J., Lin M.T., Wang H.P., Shun C.T., Sheu J.C., Lin J.T. Genetic polymorphisms of cytochrome P450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan. Int. J. Colorectal Dis. 2002, 17(5):338-343.
55. Yin L., Pu Y., Liu T.Y., Tung Y.H., Chen K.W., Lin P. Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing China. Lung Cancer 2001, 33(2-3):133-141.